Circulating levels of hepatocyte growth factor and left ventricular remodelling after acute myocardial infarction

Nicolas Lamblin1, Anne Bauters, Marie Fertin

  • 1Centre Hospitalier Régional et Universitaire de Lille, Lille Cedex, France.

Insights

Hepatocyte growth factor (HGF) levels after myocardial infarction (MI) correlate with left ventricular (LV) remodelling and predict heart failure rehospitalization. Higher HGF indicates poorer outcomes in MI patients.

Area of Science:

  • Cardiology
  • Biomarkers
  • Heart Failure

Background:

  • Experimental studies suggest hepatocyte growth factor (HGF) has cardioprotective effects after myocardial infarction (MI).
  • Understanding the role of HGF in post-MI cardiac remodeling is crucial for patient outcomes.

Purpose of the Study:

  • To investigate the relationship between circulating hepatocyte growth factor (HGF) levels and left ventricular (LV) remodeling.
  • To assess the association of HGF with clinical outcomes, including rehospitalization for heart failure after acute MI.

Main Methods:

  • Prospective multicenter study of 246 patients with first anterior Q-wave MI.
  • Serial echocardiography and blood sampling for HGF, BNP, and CRP at baseline and follow-up (1, 3, 12 months).
  • Multivariate analysis to identify independent predictors of HGF levels and outcomes.

Main Results:

  • Plasma HGF levels were elevated post-MI, correlating positively with LV volumes, systolic function indices, and BNP.
  • HGF levels were negatively associated with LV ejection fraction and positively with C-reactive protein.
  • Higher HGF levels at 1, 3, and 12 months post-MI were associated with increased mortality or heart failure rehospitalization.

Conclusions:

  • Circulating HGF levels are significantly correlated with markers of LV remodeling following MI.
  • Elevated HGF levels are associated with adverse clinical outcomes, including rehospitalization for heart failure.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...